| Year |
Citation |
Score |
| 2021 |
Abdo RA, Lamare F, Fernandez P, Bentourkia M. Quantification of Hypoxia in Human Glioblastoma using PET with 18F-FMISO. Nuclear Medicine and Molecular Imaging. 55: 107-115. PMID 34109007 DOI: 10.1007/s13139-021-00693-8 |
0.333 |
|
| 2020 |
Schollhammer R, Clermont-Gallerande HD, Robert G, Yacoub M, Lamare F, Balamoutoff N, Vimont D, Hindie E, Fernandez P, Morgat C. Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer. Journal of Clinical Oncology. 38: 21-21. DOI: 10.1200/Jco.2020.38.6_Suppl.21 |
0.351 |
|
| 2019 |
Abdo RA, Lamare F, Fernandez P, Bentourkia M. Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET. Cancer Drug Resistance (Alhambra, Calif.). 2: 131-140. PMID 35582145 DOI: 10.20517/cdr.2018.21 |
0.32 |
|
| 2019 |
Abdo RA, Lamare F, Fernandez P, Bentourkia M. Analysis of hypoxia in human glioblastoma tumors with dynamic 18F-FMISO PET imaging. Australasian Physical & Engineering Sciences in Medicine. PMID 31520369 DOI: 10.1007/s13246-019-00797-8 |
0.313 |
|
| 2019 |
Fernandez P, Zanotti-Fregonara P, Eimer S, Gimbert E, Monteil P, Penchet G, Lamare F, Perez P, Vimont D, Ledure S, Tourdias T, Loiseau H. Combining 3'-Deoxy-3'-[18F] fluorothymidine and MRI increases the sensitivity of glioma volume detection. Nuclear Medicine Communications. PMID 31469809 DOI: 10.1097/Mnm.0000000000001056 |
0.41 |
|
| 2019 |
Morgat C, Schollhammer R, Macgrogan G, Barthe N, Vélasco V, Vimont D, Cazeau AL, Fernandez P, Hindié E. Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples. Plos One. 14: e0210905. PMID 30645633 DOI: 10.1371/Journal.Pone.0210905 |
0.439 |
|
| 2018 |
Ceyrat Q, Ziade C, Tlili G, Fernandez P, Meyer M. Galactocele, Pitfall for the Evaluation by 18F-FDG PET/CT. Clinical Nuclear Medicine. 43: e237-e238. PMID 29847317 DOI: 10.1097/Rlu.0000000000002119 |
0.435 |
|
| 2018 |
Debordeaux F, Chansel-Debordeaux L, Pinaquy JB, Fernandez P, Schulz J. What about αβ integrins in molecular imaging in oncology? Nuclear Medicine and Biology. 62: 31-46. PMID 29807242 DOI: 10.1016/J.Nucmedbio.2018.04.006 |
0.737 |
|
| 2018 |
Tisseraud M, Schulz J, Vimont D, Berlande M, Fernandez P, Hermange P, Fouquet E. Highly hindered 2-(aryl-di-tert-butylsilyl)-N-methyl-imidazoles: a new tool for the aqueous F- and F-fluorination of biomolecule-based structures. Chemical Communications (Cambridge, England). PMID 29714374 DOI: 10.1039/C8Cc01782D |
0.32 |
|
| 2018 |
Merlin T, Visvikis D, Fernandez P, Lamare F. Dynamic PET image reconstruction integrating temporal regularization associated with respiratory motion correction for applications in oncology. Physics in Medicine and Biology. PMID 29339575 DOI: 10.1088/1361-6560/Aaa86A |
0.747 |
|
| 2017 |
Schollhammer R, Schwartz P, Jullie ML, Pham-Ledard A, Mercie P, Fernandez P, Pinaquy JB. 18F-FDG PET/CT Imaging of Popliteal Vasculitis Associated With Polyarteritis Nodosa. Clinical Nuclear Medicine. PMID 28574878 DOI: 10.1097/Rlu.0000000000001711 |
0.446 |
|
| 2017 |
Schollhammer R, De Clermont-Gallerande H, Fernandez P, Meyer M. Imaging of a Pelvic Textiloma Using (18)F-FDG PET/CT in a Patient With a History of Prostate Cancer: A Case Report and Review of the Literature. Clinical Genitourinary Cancer. PMID 28526417 DOI: 10.1016/J.Clgc.2017.04.027 |
0.454 |
|
| 2017 |
de Vaugelade C, de Clermont-Gallerande H, Meyer M, My Duyen Tiphaine A, Benjamin A, Ducassou S, Chateil JF, Fernandez P. FDG PET/CT in Pediatric Neurolymphomatosis. Clinical Nuclear Medicine. PMID 28288046 DOI: 10.1097/Rlu.0000000000001624 |
0.417 |
|
| 2017 |
Houard C, Pinaquy JB, Henriques DE Figueiredo B, Mesguich C, Cazeau AL, Allard JB, Laharie H, Bordenave L, Fernandez P, Vendrely V. Role of (18)F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in post-treatment evaluation of anal carcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28280225 DOI: 10.2967/Jnumed.116.185280 |
0.452 |
|
| 2017 |
Morgat C, MacGrogan G, Brouste V, Vélasco V, Sevenet N, Bonnefoi H, Fernandez P, Debled M, Hindie E. Expression of Gastrin-Releasing Peptide Receptor (GRPR) in Breast Cancer and its Association with Pathological, Biological and Clinical Parameters: A Study of 1432 Primary Tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28280221 DOI: 10.2967/Jnumed.116.188011 |
0.302 |
|
| 2017 |
Vera P, Thureau S, Chaumet-Riffaud P, Modzelewski R, Bohn P, Vermandel M, Hapdey S, Pallardy A, Mahé MA, Lacombe M, Boisselier P, Guillemard S, Olivier P, Beckendorf V, Salem N, ... ... Fernandez P, et al. Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by F-miso PET/CT in patients with non-small cell lung carcinoma [RTEP5 study]. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28254869 DOI: 10.2967/Jnumed.116.188367 |
0.407 |
|
| 2016 |
Meyer M, Fernandez P, Zanotti-Fregonara P. 18F-FDG Imaging of Chronic Inflammation Associated With Promontofixation of the Uterus. Clinical Nuclear Medicine. PMID 27819855 DOI: 10.1097/Rlu.0000000000001420 |
0.451 |
|
| 2016 |
Kryza D, Debordeaux F, Azéma L, Hassan A, Paurelle O, Schulz J, Savona-Baron C, Charignon E, Bonazza P, Taleb J, Fernandez P, Janier M, Toulmé JJ. Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas. Plos One. 11: e0149387. PMID 26901393 DOI: 10.1371/Journal.Pone.0149387 |
0.705 |
|
| 2016 |
Morgat C, Vélayoudom-Céphise FL, Schwartz P, Guyot M, Gaye D, Vimont D, Schulz J, Mazère J, Nunes ML, Smith D, Hindié E, Fernandez P, Tabarin A. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26819103 DOI: 10.1007/s00259-016-3319-3 |
0.303 |
|
| 2016 |
Sagardoy T, Fernandez P, Ghafouri A, Digue L, Haaser T, de Clermont-Galleran H, Castetbon V, de Monès E. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up. Head & Neck. 38: E1271-6. PMID 26315809 DOI: 10.1002/Hed.24204 |
0.453 |
|
| 2016 |
Morgat C, Varshney R, Vimont D, Savona-Baron C, Riès C, Chanseau C, Bertrand SS, Mishra AK, Hindié E, Fernandez P, Schulz J. Correction: A new class of radiopeptides for PET imaging of neuromedin-B receptor: 68Ga-ranatensin analogs Medchemcomm. 7: 2191-2191. DOI: 10.1039/C6Md90048H |
0.366 |
|
| 2016 |
Morgat C, Varshney R, Vimont D, Savona-Baron C, Riès C, Chanseau C, Bertrand SS, Mishra AK, Hindié E, Fernandez P, Schulz J. A new class of radiopeptides for PET imaging of neuromedin-B receptor: 68Ga-ranatensin analogs Medchemcomm. 7: 1217-1223. DOI: 10.1039/C6Md00131A |
0.302 |
|
| 2015 |
Merlin T, Visvikis D, Fernandez P, Lamare F. A novel partial volume effects correction technique integrating deconvolution associated with denoising within an iterative PET image reconstruction. Medical Physics. 42: 804-19. PMID 25652494 DOI: 10.1118/1.4905162 |
0.755 |
|
| 2015 |
Morgat C, Mazère J, Fernandez P, Buj S, Vimont D, Schulz J, Lamare F. A phantom-based method to standardize dose-calibrators for new β+-emitters. Nuclear Medicine Communications. 36: 201-6. PMID 25321161 DOI: 10.1097/Mnm.0000000000000227 |
0.351 |
|
| 2015 |
Henriques de Figueiredo B, Zacharatou C, Galland-Girodet S, Benech J, De Clermont-Gallerande H, Lamare F, Hatt M, Digue L, De Mones del Pujol E, Fernandez P. Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 191: 217-24. PMID 25245468 DOI: 10.1007/S00066-014-0752-8 |
0.488 |
|
| 2015 |
Pasticier G, Chicart M, Gross-Goupil M, Donon L, Robert G, Ferriere J, Ballanger P, Bernhard J, Cornelis F, Lebras Y, Grenier N, Ravaud A, Haaser T, Fernandez P, Clermont-Gallerande HD. Impact of the 18F- PET/CT scan in the management of patients with high-risk or intermediate-risk prostate cancer at initial diagnosis or at recurrence. Journal of Clinical Oncology. 33: 87-87. DOI: 10.1200/Jco.2015.33.7_Suppl.87 |
0.444 |
|
| 2015 |
Debordeaux F, Schulz J, Savona-Baron C, Hazari PP, Lervat C, Mishra AK, Ries C, Barthe N, Vergier B, Fernandez P. 99mTc-DTPA-bis-c(RGDfK) a potential alpha(v)beta3 integrin based homobivalent radioligand for imaging neoangiogenesis in malignant glioma and melanoma Rsc Advances. 5: 60161-60171. DOI: 10.1039/C5Ra09119E |
0.712 |
|
| 2014 |
de Figueiredo BH, Antoine M, Trouette R, Lagarde P, Petit A, Lamare F, Hatt M, Fernandez P. Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study. Radiation Oncology (London, England). 9: 300. PMID 25534014 DOI: 10.1186/S13014-014-0300-9 |
0.696 |
|
| 2014 |
Lamare F, Maitre AL, Dawood M, Schäfers KP, Fernandez P, Rimoldi OE, Visvikis D. Evaluation of respiratory and cardiac motion correction schemes in dual gated PET/CT cardiac imaging Medical Physics. 41: 72504. PMID 24989407 DOI: 10.1118/1.4881099 |
0.359 |
|
| 2014 |
de Monès E, Castetbon V, Digue L, Baltazart B, Fernandez P. Diagnosis of squamous cell carcinoma metastasis with 18F-FDG PET/CT in stoma after percutaneous endoscopic gastrostomy: a rare and poorly known iatrogenic cause of spread of head and neck cancer. Clinical Nuclear Medicine. 39: 544-6. PMID 24810782 DOI: 10.1097/Rlu.0B013E3182A23Cf6 |
0.358 |
|
| 2013 |
Figueiredo BHd, Merlin T, Clermont-Gallerande Hd, Hatt M, Vimont D, Fernandez P, Lamare F. Potential of [18F]-fluoromisonidazole positron-emission tomography for radiotherapy planning in head and neck squamous cell carcinomas. Strahlentherapie Und Onkologie. 189: 1015-1019. PMID 24173497 DOI: 10.1007/S00066-013-0454-7 |
0.756 |
|
| 2013 |
Thureau S, Chaumet-Riffaud P, Modzelewski R, Fernandez P, Tessonnier L, Vervueren L, Cachin F, Berriolo-Riedinger A, Olivier P, Kolesnikov-Gauthier H, Blagosklonov O, Bridji B, Devillers A, Collombier L, Courbon F, et al. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1543-50. PMID 23918733 DOI: 10.2967/Jnumed.112.118083 |
0.405 |
|
| 2013 |
Lamare F, Mazere J, Attila M, Mayo W, De Clermont-Gallerande H, Meissner W, Fernandez P, Allard M. Improvement of in vivo quantification of [123I]-Iodobenzovesamicol in single-photon emission computed tomography/computed tomography using anatomic image to brain atlas nonrigid registration. Molecular Imaging. 12: 288-99. PMID 23759370 DOI: 10.2310/7290.2012.00043 |
0.356 |
|
| 2013 |
Morgat C, Hindié E, Mishra AK, Allard M, Fernandez P. Gallium-68: chemistry and radiolabeled peptides exploring different oncogenic pathways. Cancer Biotherapy & Radiopharmaceuticals. 28: 85-97. PMID 23461410 DOI: 10.1089/Cbr.2012.1244 |
0.394 |
|
| 2013 |
Pogam AL, Lamare F, Hatt M, Fernandez P, Rest CCL, Visvikis D. MRI data driven partial volume effects correction in PET imaging using 3D local multi-resolution analysis Nuclear Instruments & Methods in Physics Research Section a-Accelerators Spectrometers Detectors and Associated Equipment. 702: 39-41. DOI: 10.1016/J.Nima.2012.08.038 |
0.503 |
|
| 2012 |
David S, Visvikis D, Quellec G, Le Rest CC, Fernandez P, Allard M, Roux C, Hatt M. Image change detection using paradoxical theory for patient follow-up quantitation and therapy assessment. Ieee Transactions On Medical Imaging. 31: 1743-53. PMID 22614573 DOI: 10.1109/Tmi.2012.2199511 |
0.316 |
|
| 2012 |
Thureau S, Chaumet-Riffaud P, Fernandez P, Bridji B, Houzard C, Tessonnier L, Cachin F, Modzelewski R, Vera P, Dubray B. Pd-0293 Reproducibility And Volume Segmentation Methods On F-Miso And Flt Pet-Ct Images In Patients With Lung Cancer Radiotherapy and Oncology. 103. DOI: 10.1016/S0167-8140(12)70632-1 |
0.423 |
|
| 2011 |
De Clermont H, Huchet A, Lamare F, Rivière A, Fernandez P. Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma. Clinical Nuclear Medicine. 36: e194-5. PMID 22064107 DOI: 10.1097/Rlu.0B013E3182335E20 |
0.481 |
|
| 2010 |
Farid K, Monteil P, Allard M, Fernandez P. Bleeding is a cause of false positive brain Tl-201 SPECT CT. Clinical Nuclear Medicine. 35: 459-60. PMID 20479603 DOI: 10.1097/Rlu.0B013E3181Db4E1E |
0.334 |
|
| 2009 |
Henriques de Figueiredo B, Barret O, Demeaux H, Lagarde P, De-Mones-Del-Pujol E, Kantor G, de Clermont-Gallerande H, Richaud P, Fernandez P. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 93: 479-82. PMID 19880207 DOI: 10.1016/J.Radonc.2009.09.010 |
0.485 |
|
| 2009 |
Farid K, Guyot M, Jeandot R, Durieux M, Allard M, Fernandez P. SPECT-CT improves detection of small peritoneal fistula. Clinical Nuclear Medicine. 34: 634-5. PMID 19692834 DOI: 10.1097/Rlu.0B013E3181B06A97 |
0.346 |
|
| 2009 |
Farid K, Sibon I, Fernandez P, Guyot M, Jeandot R, Allard M. Delayed acquisition and hyperglycemia improve brain metastasis detection on F-18 FDG PET. Clinical Nuclear Medicine. 34: 533-4. PMID 19617738 DOI: 10.1097/Rlu.0B013E3181Abb67E |
0.445 |
|
| 2009 |
Farid K, Sibon I, Fernandez P, Michel V, Barret O, Allard M. Tc-99m HMPAO-SPECT with CT attenuation correction improves detection of epileptogenic areas. Clinical Nuclear Medicine. 34: 290-1. PMID 19387205 DOI: 10.1097/Rlu.0B013E31819E5183 |
0.329 |
|
| 2008 |
Laffon E, Cazeau AL, Monet A, de Clermont H, Fernandez P, Marthan R, Ducassou D. The effect of renal failure on 18F-FDG uptake: a theoretic assessment. Journal of Nuclear Medicine Technology. 36: 200-2. PMID 19008285 DOI: 10.2967/Jnmt.107.049627 |
0.38 |
|
| 2007 |
Fernandez P, Guyot M, Lazaro E, Viallard JF, Allard M, Ducassou D. Systemic tuberculosis presenting as an epiglottic mass detected on F-18 FDG PET/CT. Clinical Nuclear Medicine. 32: 719-24. PMID 17710028 DOI: 10.1097/Rlu.0B013E318123F7Fb |
0.471 |
|
| Show low-probability matches. |